CCL2 and ovarian cancer: Recently, our group purified human recombinant CCL2 proteins and showed that exogenous CCL2 improved ovarian cancer cell proliferation by stimulating the MAPK/ERK signaling pathway and regulating JUN, RELB, and NF-κB2 expression levels [50].